<DOC>
	<DOCNO>NCT02460861</DOCNO>
	<brief_summary>This project detection occult tumor cell surgical margin radical prostatovesiculectomy analyse methylation status Glutathione S-transferase P 1 ( GSTP1 ) . After gland excision specimen obtain 9 defined area prostatic fossa . The biopsy divide two part . One part use histopathological analysis part moleculargenetic analysis . Results correlate e.g . tumor stage , Gleason Score prostate specific antigen ( PSA ) . The prostate-cancer-negative control group bladder cancer .</brief_summary>
	<brief_title>Intraoperational Prostate Loge Biopsies ( iPROLOGX ) After Radical Prostatovesiculectomy</brief_title>
	<detailed_description>This project detection occult tumor cell surgical margin radical prostatovesiculectomy analyse methylation status Glutathione S-transferase P 1 ( GSTP1 ) . After gland excision specimen obtain 9 defined area prostatic fossa . The biopsy divide two part . One part use histopathological analysis part moleculargenetic analysis . Results correlate e.g . tumor stage , Gleason Score prostate specific antigen ( PSA ) . The prostate-cancer-negative control group bladder cancer . DNA ISOLATION DNA biopsy store -80°C isolate use innuPREP DNA mini Kit ( Analytik Jena , Jena , Germany ) follow protocol 1 manufacturer 's instruction . DNA elute 50 µl elution buffer . Concentration purity analyse use Nanodrop 2000 . DNA BISULFITE MODIFICATION DNA modify use EpiTect Bisulfite Kit ( QIAGEN , Hilden , Germany ) accord manufacturer 's instruction . Samples elute 20 µl elution buffer . QUANTITATIVE METHYLATION SPECIFIC PCR Methylation status GSTP1 analyse quantitative methylation-specific PCR ( Q-MSP ) use StepOnePlus Real-Time PCR System StepOne Software v2.1 Applied Biosystems ( Darmstadt , Germany ) . Q-MSP perform duplicate analysing gene Actin GSTP1 . The primer ' test probe ' sequence use amplify detect hypermethylated GSTP1 : 5'-AgTTgCgCggCgATTTC ( forward primer ) , 5'-gCCCCAATACTAAATCACgACg ( reverse primer ) 5'-CggTCgACgTTCggggTgTAgCg ( taqman probe ) , label fluorescence dye FAM . The primer ' test probe ' sequence use amplify detect Actin : 5'-TggTgATggAggAggTTTAgTAAgT ( forward primer ) , 5'-AACCAATAAAACCTACTCCTCCCTTAA ( reverse primer ) ,5'-ACCACCACCCAACACACAATAACAAACACA ( taqman probe ) , label fluorescence dye VIC . The Q-MSP carry 50°C 2 min. , 95°C 15 min . follow 50 cycle 95°C 1 60°C 1 min . As positive control bisulfite-converted DNA DU145 LNCap use . Blank reaction destillated water , replace DNA , serve negative control ( NTC ) .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Criteria patient prostate adenocarcinoma : Inclusion Criteria sex : male diagnosis : prostate adenocarcinoma treatment : radical prostatovesiculectomy period treatment : 11/30/2011 10/15/2013 Exclusion Criteria sex : female diagnosis : prostate adenocarcinoma treatment : radical prostatovesiculectomy period treament : 11/30/2011 10/15/2013 Criteria prostate adenocarcinoma negative control group : Inclusion Criteria sex : male diagnosis : urothelial carcinoma treatment : cystoprostatectomy period treament : 12/14/2011 02/18/2014 Exclusion Criteria sex : female diagnosis : incidental prostate adenocarcinoma treatment : cystoprostatectomy period treatment : 12/14/2011 02/18/2014</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Molecular staging</keyword>
	<keyword>GSTP1</keyword>
	<keyword>Surgical margin</keyword>
	<keyword>prostatovesiculectomy</keyword>
</DOC>